Differential interactions of the homeodomain-interacting protein kinase 2 (HIPK2) by phosphorylation-dependent sumoylation

被引:34
作者
Sung, KS
Go, YY
Ahn, JH
Kim, YH
Kim, Y
Choi, CY
机构
[1] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Samsung Biomed Res Inst, Suwon 440746, South Korea
[3] Digital Biotech, Ansan 425839, South Korea
[4] Natl Heart Lung & Blood Inst, Lab Res Program, NIH, Bethesda, MD 20892 USA
来源
FEBS LETTERS | 2005年 / 579卷 / 14期
关键词
homeodomain-interacting protein kinase 2; small ubiquitin-like modifier 1; phosphorylation; differential interaction;
D O I
10.1016/j.febslet.2005.04.053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Homeodomain-interacting protein kinase 2 (HIPK2) interacts with and phosphorylates various transcription factors that are critical regulators of cell fate decisions and apoptosis during development. Here we show that lysine 25 of HIPK2 is the major sumoylation site, both in vitro and in vivo, and that the sumoylation of this site occurs in a phosphorylation-dependent manner. This became clear with the finding that kinase-dead HIPK2 (K221R) could not be efficiently sumoylated in vitro. The sumoylation of HIPK2 resulted in the disruption of its interaction with a Groucho corepressor. Consequently, sumoylation inhibited the regulatory activity of HIPK2 on the Groucho-mediated repression of transcription, whereas not on p53-mediated transactivation. These results suggest that phosphorylation-dependent sumoylation enables HIPK2 to drive different target gene transcription by means of differential interactions with its binding partners. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:3001 / 3008
页数:8
相关论文
共 29 条
[1]   Identification and sequence of human PKY, a putative kinase with increased expression in multidrug-resistant cells, with homology to yeast protein kinase Yak1 [J].
Begley, DA ;
Berkenpas, MB ;
Sampson, KE ;
Abraham, I .
GENE, 1997, 200 (1-2) :35-43
[2]   Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis [J].
Busino, L ;
Chiesa, M ;
Draetta, GF ;
Donzelli, M .
ONCOGENE, 2004, 23 (11) :2050-2056
[3]   The homeodomain protein NK-3 recruits Groucho and a histone deacetylase complex to repress transcription [J].
Choi, CY ;
Kim, YH ;
Kwon, HJ ;
Kim, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (47) :33194-33197
[4]   Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis [J].
D'Orazi, G ;
Cecchinelli, B ;
Bruno, T ;
Manni, I ;
Higashimoto, Y ;
Saito, S ;
Gostissa, M ;
Coen, S ;
Marchetti, A ;
Del Sal, G ;
Piaggio, G ;
Fanciulli, M ;
Appella, E ;
Soddu, S .
NATURE CELL BIOLOGY, 2002, 4 (01) :11-19
[5]   SUMO-1 modification of IκBα inhibits NF-κB activation [J].
Desterro, JMP ;
Rodriguez, MS ;
Hay, RT .
MOLECULAR CELL, 1998, 2 (02) :233-239
[6]   Regulation of transcription factors by protein degradation [J].
Desterro, JMP ;
Rodriguez, MS ;
Hay, RT .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (8-9) :1207-1219
[7]   Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis [J].
Di Stefano, V ;
Rinaldo, C ;
Sacchi, A ;
Soddu, S ;
D'Orazi, G .
EXPERIMENTAL CELL RESEARCH, 2004, 293 (02) :311-320
[8]   Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity [J].
Gill, G .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2003, 13 (02) :108-113
[9]   Covalent modification of human homeodomain interacting protein kinase 2 by SUMO-1 at lysine 25 affects its stability [J].
Gresko, E ;
Möller, A ;
Roscic, A ;
Schmitz, ML .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 329 (04) :1293-1299
[10]   Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis [J].
Hayakawa, F ;
Privalsky, ML .
CANCER CELL, 2004, 5 (04) :389-401